ConductScience.org, home

Paper17907263

Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate.

Roth T and 3 others. Hum Psychopharmacol, 2008. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate. Papers, record 17907263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17907263

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate.
PubMed
Journal
Hum Psychopharmacol
PubMed
Year
2008
PubMed
Publication types
Evaluation Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
0.89
iCite
Revised in PubMed
2024-03-22
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Roth TThomas
2Mayleben DDavid
3Corser BCBruce C
4Singh NNNikhilesh N

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Circadian RhythmMajor topic
Hypnotics and SedativesMajor topic
PyridinesMajor topic
Administration, Sublingual
Adult
Analysis of Variance
Cross-Over Studies
Dose-Response Relationship, Drug
Double-Blind Method
Female
Humans
Male
Pain Measurement
Psychomotor Performance
Time Factors
Zolpidem

Source PubMed

Download CSV of topics

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110394608Insomnia in primary care patients.Sleep1999https://conductscience.org/library/papers/10394608PubMed
28861737The effect of co-administration of zolpidem with fluoxetine: pharmacokinetics and pharmacodynamics.Int J Clin Pharmacol Ther1996https://conductscience.org/library/papers/8861737PubMed
38071269A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.J Clin Psychiatry1994https://conductscience.org/library/papers/8071269PubMed
47846196EEG profile of intravenous zolpidem in healthy volunteers.Psychopharmacology (Berl)1994https://conductscience.org/library/papers/7846196PubMed
57976454Prevalence of insomnia in elderly general practice attenders and the current treatment modalities.Acta Psychiatr Scand1994https://conductscience.org/library/papers/7976454PubMed
612454557Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.J Clin Psychopharmacol2002https://conductscience.org/library/papers/12454557PubMed
717907263Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate.Hum Psychopharmacol2008https://conductscience.org/library/papers/17907263PubMed
86151847Pencil and paper tests--sensitivity to psychotropic drugs.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6151847PubMed
914607350Effects of after-midnight intake of zolpidem and temazepam on driving ability in women with non-organic insomnia.Sleep Med2003https://conductscience.org/library/papers/14607350PubMed
107809569Sleep onset insomnia, sleep maintaining insomnia and insomnia with early morning awakening--temporal stability of subtypes in a longitudinal study on general practice attenders.Sleep1994https://conductscience.org/library/papers/7809569PubMed
112858188Insomnia and its treatment. Prevalence and correlates.Arch Gen Psychiatry1985https://conductscience.org/library/papers/2858188PubMed
129378841Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans.J Clin Pharmacol1997https://conductscience.org/library/papers/9378841PubMed
1316517453Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies.Ann Clin Psychiatry2006https://conductscience.org/library/papers/16517453PubMed
143698460Sedative effects and impaired learning and recall after single oral doses of lorazepam.Clin Pharmacol Ther1986https://conductscience.org/library/papers/3698460PubMed
159834048Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.Clin Pharmacol Ther1998https://conductscience.org/library/papers/9834048PubMed
167862941Sedative, memory, and performance effects of hypnotics.Psychopharmacology (Berl)1994https://conductscience.org/library/papers/7862941PubMed

Download CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
25668292Sensitivity and validity of psychometric tests for assessing driving impairment: effects of sleep deprivation.PLoS One2015https://conductscience.org/library/papers/25668292PubMed
25246162Pharmacokinetics of zolpidem from sublingual zolpidem tartrate tablets in healthy elderly versus non-elderly subjects.Drugs Aging2014https://conductscience.org/library/papers/25246162PubMed
24649369Fast-Acting Sublingual Zolpidem for Middle-of-the-Night Wakefulness.Sleep Disord2014https://conductscience.org/library/papers/24649369PubMed
24587571Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use.Sleep2014https://conductscience.org/library/papers/24587571PubMed
24408210Alcohol calibration of tests measuring skills related to car driving.Psychopharmacology (Berl)2014https://conductscience.org/library/papers/24408210PubMed
23853559Middle-of-the-night hypnotic use in a large national health plan.J Clin Sleep Med2013https://conductscience.org/library/papers/23853559PubMed
23616698New approaches in the treatment of short term and middle of the night insomnia: emerging evidence for a role for sublingual zolpidem tablets.Nat Sci Sleep2010https://conductscience.org/library/papers/23616698PubMed
23372266
Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.
Sleep2013https://conductscience.org/library/papers/23372266PubMed
19090322APD125, a selective serotonin 5-HT(2A) receptor inverse agonist, significantly improves sleep maintenance in primary insomnia.Sleep2008https://conductscience.org/library/papers/19090322PubMed
18788653Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings.Sleep2008https://conductscience.org/library/papers/18788653PubMed
17907263Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate.Hum Psychopharmacol2008https://conductscience.org/library/papers/17907263PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17907263

GET https://conductscience.org/api/papers/v1/17907263/authors